UK markets closed

Pixium Vision SA (0QVB.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.0945-0.0968 (-50.60%)
At close: 05:03PM GMT
Full screen
Previous close0.1913
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0000 - 0.0000
52-week range
Volume18,601
Avg. volumeN/A
Market cap18,488
Beta (5Y monthly)0.50
PE ratio (TTM)N/A
EPS (TTM)-0.2310
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Extraordinary General Meeting of February 15, 2023: Notice of publication of the preparatory documents

    Extraordinary General Meeting of February 15, 2023: Notice of publication of the preparatory documents Paris, France, January 27, 2023 – 6.00 pm CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, informs its shareholders that an Extraordinary General Meeting of the Company will be held on Wednesday February 15, 2023, at 2.00 pm CET at th

  • Globe Newswire

    Pixium Vision convenes an Extraordinary General Meeting of Shareholders on February 15, 2023

    Pixium Vision convenes an Extraordinary General Meeting of Shareholders on February 15, 2023 Paris, France, January 20, 2023 – 19:00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces today that it will hold an extraordinary general meeting of shareholders (EGM) at 14:00 CET on February 15, 2023 at Pixium Vision’s headquarter of

  • Globe Newswire

    Pixium Vision announces peer-reviewed publications demonstrating the potential of the Next Generation PRIMA implant to restore vision at five times higher resolution than current implant

    Pixium Vision announces peer-reviewed publications demonstrating the potential of the Next Generation PRIMA implant to restore vision at five times higher resolution than current implant New implants leverage existing PRIMA design with significant increase in spatial resolutionPotential to restore vision to levels sufficient for face recognition and reading smaller fonts: 20/100 with no magnification and up to 20/20 with electronic magnificationData on the new implants published in top-tier scie